Video

Urology Times 50 Innovations Series: Intralesional therapies for Peyronie's disease

Author(s):

Urology Times staff

"Peyronie's disease has really seen a wide range of intralesional options through the years," says Denise Asafu-Adjei, MD, MPH.

Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Denise Asafu-Adjei, MD, MPH, discusses the development of intralesional therapies for Peyronie’s disease and how they have improved the treatment of this condition. Asafu-Adjei is a urologist and medical director of male reproductive medicine at Loyola University, Chicago, Illinois.

Related Videos
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Elia Abou Charaweb, MD, answers a question during a video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Justin Dubin, MD, answers a question during a video interview
Michael Jenson, PA-C, answers a question during a Zoom video interview
Man talking with doctor | Image Credit: © RFBSIP - stock.adobe.com
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
Man talking with doctor | Image Credit: © RFBSIP - stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Related Content
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
December 17th 2024

Sexual QOL improved at 12 months following AUS placement

LeRoy Jones, MD
"I think this is a very important trial, just to bring some importance about patients' worries about being sexually active with urinary incontinence," says LeRoy Jones, MD.
Destigmatizing Urology: Dr. Schlegel discusses male infertility
January 24th 2022

Destigmatizing Urology: Dr. Schlegel discusses male infertility

Urology Times staff
“The urologist's role is to try to normalize what is going on and provide easier access,” says Peter N. Schlegel, MD.
Low-intensity shockwave therapy, plasma injections efficacious for erectile dysfunction
October 20th 2024

Low-intensity shockwave therapy, plasma injections efficacious for erectile dysfunction

Kevin Kunzmann
SMSNA 2024 abstract data show shockwave therapies and platelet-rich plasma, either alone or in combination, may be promising treatments for ED.
Destigmatizing Urology: Dr. Burnett discusses sexual dysfunction in men
October 18th 2021

Destigmatizing Urology: Dr. Burnett discusses sexual dysfunction in men

Urology Times staff
“That's certainly the most significant stigma, the stigma that you're not quite the man that you want to be or what you perceive your partner wants you to be,” says Arthur L. Burnett, MD, MBA, FACS.
Men with severe ED more than twice likely to have high ceramide levels
October 18th 2024

Men with severe ED more than twice likely to have high ceramide levels

Kevin Kunzmann
New research better defines the link between cardiovascular disease risk and prevalence of ED per serum ceramide levels.
Severe obesity linked to high risk of low sperm count
October 18th 2024

Severe obesity linked to high risk of low sperm count

Kevin Kunzmann
Data from a new SMSNA 2024 abstract show an association between significantly high BMI and risk of azoospermia and oligospermia.
© 2024 MJH Life Sciences

All rights reserved.